The research, part of a series of papers published in Nature Communications, is led by Professor Martin Widschwendter (UCL Institute for Women’s Health, University of Innsbruck and the European Translational Oncology Prevention and Screening Institute) and is funded by The Eve Appeal and the European Research Council. For more details - UCL news